Login / Signup

Severe infusion-related reaction to crizanlizumab in an adolescent with sickle cell disease.

Kristine A KarkoskaCharles T QuinnKelly ClappPatrick T McGann
Published in: American journal of hematology (2020)
Keyphrases
  • young adults
  • mental health
  • low dose
  • early onset
  • drug induced
  • childhood cancer